Literature DB >> 11409999

Angiotensin I converting enzyme inhibitory peptides purified from bovine skin gelatin hydrolysate.

S K Kim1, H G Byun, P J Park, F Shahidi.   

Abstract

Bovine skin gelatin was hydrolyzed with sequential protease treatments in the order of Alcalase, Pronase E, and collagenase using a three-step ultrafiltration membrane reactor. The molecular weight distributions of the first, second, and third hydrolysates were 4.8-6.6, 3.4-6.6, and 0.9-1.9 kDa, respectively. The angiotensin I converting enzyme (ACE) inhibitory activity of the third hydrolysate (IC(50) = 0.689 mg/mL) was higher than that of the first and second hydrolysates. Two different peptides showing strong ACE inhibitory activity were isolated from the hydrolysate using consecutive chromatographic methods including gel filtration chromatography, ion-exchange chromatography, and reversed-phase high-performance liquid chromatography. The isolated peptides were composed of Gly-Pro-Leu and Gly-Pro-Val and showed IC(50) values of 2.55 and 4.67 microM, respectively.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11409999     DOI: 10.1021/jf001119u

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  15 in total

Review 1.  Bioactive peptides of animal origin: a review.

Authors:  Z F Bhat; Sunil Kumar; Hina Fayaz Bhat
Journal:  J Food Sci Technol       Date:  2015-01-21       Impact factor: 2.701

2.  Neuroprotective activities of enzymatically hydrolyzed peptides from porcine hide gelatin.

Authors:  Shaoyun Wang; Deng-Shun Wang; Rui Wang
Journal:  Int J Clin Exp Med       Date:  2008-08-10

3.  Casein fermentate of Lactobacillus animalis DPC6134 contains a range of novel propeptide angiotensin-converting enzyme inhibitors.

Authors:  M Hayes; C Stanton; H Slattery; O O'Sullivan; C Hill; G F Fitzgerald; R P Ross
Journal:  Appl Environ Microbiol       Date:  2007-05-04       Impact factor: 4.792

4.  ACE inhibitory activity of pangasius catfish (Pangasius sutchi) skin and bone gelatin hydrolysate.

Authors:  Fatemeh Mahmoodani; Masomeh Ghassem; Abdul Salam Babji; Salma Mohamad Yusop; Roya Khosrokhavar
Journal:  J Food Sci Technol       Date:  2012-05-18       Impact factor: 2.701

5.  Effect of phlorotannins isolated from Ecklonia cava on angiotensin I-converting enzyme (ACE) inhibitory activity.

Authors:  W A J P Wijesinghe; Seok-Chun Ko; You-Jin Jeon
Journal:  Nutr Res Pract       Date:  2011-04-23       Impact factor: 1.926

6.  Antioxidant effect of a marine oligopeptide preparation from chum salmon (Oncorhynchus keta) by enzymatic hydrolysis in radiation injured mice.

Authors:  Ruiyue Yang; Junbo Wang; Zhigang Liu; Xinrong Pei; Xiaolong Han; Yong Li
Journal:  Mar Drugs       Date:  2011-11-10       Impact factor: 6.085

Review 7.  Bioactive peptides from muscle sources: meat and fish.

Authors:  Joseph Thomas Ryan; Reynolds Paul Ross; Declan Bolton; Gerald F Fitzgerald; Catherine Stanton
Journal:  Nutrients       Date:  2011-08-31       Impact factor: 5.717

8.  Effects of dietary gelatin hydrolysates on bone mineral density in magnesium-deficient rats.

Authors:  Teruyuki Noma; Satoshi Takasugi; Miho Shioyama; Taketo Yamaji; Hiroyuki Itou; Yoshio Suzuki; Keishoku Sakuraba; Keisuke Sawaki
Journal:  BMC Musculoskelet Disord       Date:  2017-09-05       Impact factor: 2.362

Review 9.  STRUCTURAL CHARACTERISTICS AND ANTIHYPERTENSIVE EFFECTS OF ANGIOTENSIN-I-CONVERTING ENZYME INHIBITORY PEPTIDES IN THE RENIN-ANGIOTENSIN AND KALLIKREIN KININ SYSTEMS.

Authors:  Sivananthan Manoharan; Adawiyah Suriza Shuib; Noorlidah Abdullah
Journal:  Afr J Tradit Complement Altern Med       Date:  2017-01-13

10.  Identification, structure-activity relationship and in silico molecular docking analyses of five novel angiotensin I-converting enzyme (ACE)-inhibitory peptides from stone fish (Actinopyga lecanora) hydrolysates.

Authors:  Shehu Muhammad Auwal; Najib Zainal Abidin; Mohammad Zarei; Chin Ping Tan; Nazamid Saari
Journal:  PLoS One       Date:  2019-05-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.